| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.20B | +23.3% |
| Cost of Revenue | $1.05B | +35.7% |
| Gross Profit | $148.3M | -24.9% |
| R&D Expense | $150.6M | +45.7% |
| SG&A Expense | $167.7M | +37.3% |
| Operating Income | -$261.0M | -127.9% |
| Interest Expense | $53.5M | -22.5% |
| Pre-tax Income | -$314.0M | -63.3% |
| Income Tax | $1.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $348.5M | -12.0% |
| Accounts Receivable | $251.0M | +185.9% |
| Inventory | $268.4M | +87.2% |
| Current Assets | $1.06B | +30.9% |
| Total Assets | $1.95B | +12.8% |
| Current Liabilities | $541.9M | +58.2% |
| Long-term Debt | $411.6M | -21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$191.7M | -216.0% |
| Capital Expenditures | $116.8M | +134.5% |
| Investing Cash Flow | -$116.8M | -150.2% |
| Financing Cash Flow | $211.4M | -31.0% |
| Free Cash Flow | -$308.5M | -179.2% |
| +4.9% |
| Net Income | -$315.1M | -91.6% |
| EPS (Basic) | -$1.62 | -70.5% |
| EPS (Diluted) | -$1.62 | -70.5% |
| Total Liabilities |
| $1.57B |
| +3.2% |
| Stockholders' Equity | $340.8M | +868.8% |